Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Morii

Showing results (381-390 of 425) with videos related to

Pageof 43
Sort By:
Archives of Biochemistry and Biophysics|November 1, 1987
Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60M Inaba, S Okuno, Y Nishizawa, et al.
Analytical Biochemistry|September 1, 1992
A new, highly sensitive assay for 1,25-dihydroxyvitamin D not requiring high-performance liquid chromatography: application of monoclonal antibody against vitamin D receptor to radioreceptor assayH Koyama, J M Prahl, A Uhland, et al.
Diabetes Care|September 4, 1998
Sympathetic function test of vasoconstrictor changes in foot arteries in diabetic patientsT Takahashi, Y Nishizawa, M Emoto, et al.
Nephron|January 1, 1988
In vivo effect of 1 alpha-hydroxyvitamin D3 on interleukin-2 production in hemodialysis patientsT Tabata, T Shoji, K Kikunami, et al.
Contributions to Nephrology|January 1, 1989
Dose-finding, double-blind, clinical trial of recombinant human erythropoietin (Chugai) in Japanese patients with end-stage renal disease. Research Group for Clinical Assessment of rhEPOM Suzuki, Y Hirasawa, K Hirashima, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1986
The effect of 1 alpha-hydroxyvitamin D3 on cell-mediated immunity in hemodialyzed patientsT Tabata, R Suzuki, K Kikunami, et al.
Nephron|January 1, 1986
Acute renal failure in McArdle's diseaseT Tabata, K Kikunami, Y Matsushita, et al.
Angiology|January 5, 2002
tPA via infusion catheters followed by continuous IV infusion for 3 days prevents intimal hyperplasia after balloon injuryK Kanamasa, Y Inoue, N Otani, et al.
Journal of Cardiovascular Pharmacology|February 24, 2001
Suppression of cell proliferation by tissue plasminogen activator during the early phase after balloon injury minimizes intimal hyperplasia in hypercholesterolemic rabbitsK Kanamasa, N Otani, N Ishida, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 7, 2000
Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetesM Inaba, Y Nishizawa, K Mita, et al.
Pageof 43

Showing results (381-390 of 425) with videos related to

Sort By:
Pageof 43
Archives of Biochemistry and Biophysics|November 1, 1987
Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60M Inaba, S Okuno, Y Nishizawa, et al.
Analytical Biochemistry|September 1, 1992
A new, highly sensitive assay for 1,25-dihydroxyvitamin D not requiring high-performance liquid chromatography: application of monoclonal antibody against vitamin D receptor to radioreceptor assayH Koyama, J M Prahl, A Uhland, et al.
Diabetes Care|September 4, 1998
Sympathetic function test of vasoconstrictor changes in foot arteries in diabetic patientsT Takahashi, Y Nishizawa, M Emoto, et al.
Nephron|January 1, 1988
In vivo effect of 1 alpha-hydroxyvitamin D3 on interleukin-2 production in hemodialysis patientsT Tabata, T Shoji, K Kikunami, et al.
Contributions to Nephrology|January 1, 1989
Dose-finding, double-blind, clinical trial of recombinant human erythropoietin (Chugai) in Japanese patients with end-stage renal disease. Research Group for Clinical Assessment of rhEPOM Suzuki, Y Hirasawa, K Hirashima, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1986
The effect of 1 alpha-hydroxyvitamin D3 on cell-mediated immunity in hemodialyzed patientsT Tabata, R Suzuki, K Kikunami, et al.
Nephron|January 1, 1986
Acute renal failure in McArdle's diseaseT Tabata, K Kikunami, Y Matsushita, et al.
Angiology|January 5, 2002
tPA via infusion catheters followed by continuous IV infusion for 3 days prevents intimal hyperplasia after balloon injuryK Kanamasa, Y Inoue, N Otani, et al.
Journal of Cardiovascular Pharmacology|February 24, 2001
Suppression of cell proliferation by tissue plasminogen activator during the early phase after balloon injury minimizes intimal hyperplasia in hypercholesterolemic rabbitsK Kanamasa, N Otani, N Ishida, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 7, 2000
Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetesM Inaba, Y Nishizawa, K Mita, et al.
Pageof 43